Approved Research
Association of type 2 diabetes, according to the number of risk factors within target range, with risk of depression
Principal Investigator: Dr Thomas van Sloten
Approved Research ID: 81410
Approval date: February 22nd 2022
Approved Research ID: 81410
Approval date: February 22nd 2022
Lay summary
Individuals with diabetes have a higher risk of developing depression compared to individuals without diabetes. The extent to which this excess risk may be reduced by current treatment is unclear. Current treatment consists of targeting multiple factors, including high blood sugar levels, elevated blood pressure, being overweight, smoking and elevated protein levels in urine. In this project, we will evaluate to which extent the risk of depression in diabetes may be potentially mitigated by this multifactorial treatment. This will inform patients and medical doctors about the potential beneficial effects of current treatments. The estimated project duration is 12 months.